Bibliography

Found 55 results

Filters: Keyword is HIV [Clear All Filters]

Conference Paper

Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D. Monocyte Activation Markers in Cerebrospinal Fluid Are Associated with Impaired Neurocognitive Testing in Advanced HIV Infection. In: AAN Meeting. AAN Meeting. New Orleans, Louisiana; 2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22569268

Journal Article

Clifford DB, Vaida F, Kao Y-ting, Franklin D, Letendre S, Collier AC, Marra CM, Gelman B, McArthur JC, Morgello S, et al. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.

Akay C, Lindl KA, Shyam N, Nabet B, Goenaga-Vazquez Y, Ruzbarsky J, Wang Y, Kolson DL, Jordan-Sciutto KL. Activation status of integrated stress response pathways in neurones and astrocytes of HIV-associated neurocognitive disorders (HAND) cortex. Neuropathology and Applied Neurobiology [Internet]. 2012 ;38(2):175-200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21883374

Fields J, Dumaop W, Rockenstein E, Mante M, Spencer B, Grant I, Ellis RJ, Letendre S, Patrick C, Adame A, et al. Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of NeuroVirology [Internet]. 2013 ;19(1):89-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23341224

Mindt MRivera, Miranda C, Arentoft A, Byrd D, Monzones J, Fuentes A, Arias F, Rentería MA, Rosario A, Morgello S. Aging and HIV/AIDS: neurocognitive implications for older HIV-positive Latina/o adults. Behavoiral Medicine [Internet]. 2014 ;40(3):116-123. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25090364

Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E. Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology [Internet]. 2013 ;8(5):1197-1209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24292993

Cassol E, Misra V, Morgello S, Gabuzda D. Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection. Journal of NeuroImmune Pharmacology [Internet]. 2013 ;8(5):1087-1097. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24259252

Robinson-Papp JS, Elliott K, Pizzirusso M, Morgello S. Autonomic neuropathy in HIV: A case report and review of potential symptoms in an advanced-stage, HIV cohort. World Journal of AIDS [Internet]. 2012 ;2:265-269. Available from: http://www.scirp.org/journal/PaperInformation.aspx?paperID=22612

Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Current HIV Research [Internet]. 2014 ;12(2):97-110. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24862332

Archibald SL, McCutchan JA, Sanders C, Wolfson T, Jernigan TL, Ellis RJ, Ances BM, Collier AC, McArthur JC, Morgello S, et al. Brain morphometric correlates of metabolic variables in HIV: the CHARTER study. J Neurovirol. 2014 ;20(6):603-11.

Gianella S, Taylor J, Brown TR, Kaytes A, Achim CL, Moore DJ, Little SJ, Ellis RJ, Smith DM. Can research at the end of life be a useful tool to advance HIV cure?. AIDS. 2017 ;31(1):1-4.

Levine AJ, Singer EJ, Sinsheimer JS, Hinkin CH, Papp J, Dandekar S, Giovanelli A, Shapshak P. CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehavioral HIV Medicine [Internet]. 2009 ;1:1-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20725607

Veenstra M, Byrd D, Inglese M, Buyukturkoglu K, Williams DW, Fleysher L, Li M, Gama L, Leon-Rivera R, Calderon TM, et al. CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?. Journal of Neuroimmune Pharmacology [Internet]. 2018 ;14. Available from: https://doi.org/10.1007/s11481-018-9792-7

Kim W-K, Alvarez X, Fisher J, Bronfin B, Westmoreland S, McLaurin J, Williams KC. CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. The American Journal of Pathology [Internet]. 2006 ;168(3):822-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16507898

Mehta SR, Pérez-Santiago J, Hulgan T, Day TRC, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, et al. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. J Neuroinflammation. 2017 ;14(1):72.

Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS [Internet]. 2014 ;28(11):1579-1591. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24752083

Pacifici M, Delbue S, Ferrante P, Jeansonne D, Kadri F, Nelson S, Velasco-Gonzalez C, Zabaleta J, Peruzzi F. Cerebrospinal Fluid miRNA Profile in HIV-Encephalitis. Journal of Cellular Physiology [Internet]. 2013 ;228(5):1070-1075. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23042033

Adiga R, Ozdemir AY, Carides A, Wasilewski M, Yen W, Chitturi P, Ellis RJ, Langford D. Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count. Journal of NeuroVirology [Internet]. 2014 ;20(4):371-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24817145

Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre SL, Ellis RJ, et al. Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011 ;17(3):248-57.

Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, l’Heureux D, Régulier EG, Richardson MW, Amini S, Morgello S, Khalili K, et al. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. Journal of NeuroVirology [Internet]. 2001 ;7(6):528-541. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11704885

Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012 ;26(6):894-908.

Rohit M, Levine AJ, Hinkin CH, Abramyan S, Saxton EH, Valdes-Sueiras M, Singer EJ. Education correction using years in school or reading grade-level equivalent? Comparing the accuracy of two methods in diagnosing HIV-associated neurocognitive impairment. Journal of the International Neuropsychological Society (JINS) [Internet]. 2007 ;13(3):462-470. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17445295

Saloner R, Heaton RK, Campbell LM, Chen A, Franklin D, Ellis RJ, Collier AC, Marra C, Clifford DB, Gelman B, et al. Effects of comorbidity burden and age on brain integrity in HIV. AIDS. 2019 ;33(7):1175-1185.

Festa L, Meucci O. Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism. Current HIV Research [Internet]. 2012 ;10(5):453-462. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=22591369

Suh H-S, Lo Y, Choi N, Letendre S, Lee SC. Evidence of the innate antiviral and neuroprotective properties of progranulin. PLoS One. 2014 ;9(5):e98184.

Pages